Studies on Fc-epsilon-RI as an antigen presentation structure at mucosal surfaces
Studies on Fc-epsilon-RI as an antigen presentation structure at mucosal surfaces
批准号:
7691540
负责人:
Elisabeth Edda Fiebiger
金额:
$42.25万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-26 至 2009-06-14
关键词:
AddressAffectAffinityAllergicAnimalsAntigen PresentationAntigen-Presenting CellsAntigensBasophilsBindingBiologyCell LineCell membraneCell modelCell surfaceCellsChargeComplexCore ProteinCross PresentationDendritic CellsDiseaseEffector CellEndoplasmic ReticulumEnvironmentEpitopesEventFc ReceptorFc epsilon RIGastrointestinal tract structureGenetic PolymorphismGoalsHumanHypersensitivityITGAX geneIgEIgE ReceptorsImmediate hypersensitivityImmuneImmune responseIndividualInflammatory ResponseInterleukin 2 Receptor GammaIntestinal MucosaIntestinesKnock-in MouseMHC Class I GenesMHC Class II GenesMediatingMonitorMucosal Immune ResponsesMusMutationPathway interactionsPatientsPatternProcessProtein IsoformsRegulationResearchRoleSignal TransductionStructureSurfaceT-Cell ActivationTailTestingTissuesTransgenic AnimalsTransmembrane DomainTransport Processabstractingcell typeclinically relevantcrosslinkdensitydimerdisorder controleosinophilin vivoin vivo Modelmacrophagemast cellneutrophilprogramspromoterreceptorreceptor bindingreceptor expressionresearch studyresponsetraffickinguptake
中文摘要
摘要
这项研究的目标是检验胃肠道树突状细胞(DC)的假设
肠道通过Fc-epsilon-RI-IgE介导的肠腔抗原摄取,从而影响肠道
炎症反应和I型超敏反应。Fc-epsilon-RI是一种高亲和力的IgE Fc受体。
多聚体免疫识别受体,通过其阿尔法链上的单价表位与IgE结合。
抗原诱导的IgE-Fc-epsilon-RI复合体的交联通过信号亚单位引起细胞激活
受体(Fc-epsilon-RI-beta和常见伽马链的二聚体)的结合。FC-epsilon的一个独特功能-
RI是其细胞类型和物种特异性的表达模式。在小鼠中,该受体仅表达为
肥大细胞和嗜碱性粒细胞上的异四聚体(α、β和两条伽马链)。在人类中,Fc-epsilon-RI
在肥大细胞和嗜碱性粒细胞上作为异四聚体组装,但另外也作为缺乏
β亚基。独特的是,人的Fc-epsilon-RI的异三聚体形式在抗原提呈时表达
细胞,包括肠道中的树突状细胞。受体的表面表达与过敏性疾病相关,并且
控制过敏反应过程中由IgE介导的细胞激活。与其他多聚体免疫识别不同
受体,表面表达是在亚单位的共翻译组装水平上调节的
内质网;但其调节机制尚不清楚。目标1将阐明结构
单个Fc-epsilon-RI亚基的特征决定了受体的组装,从而决定了Fcepsilon的表面表达-
RI复合体。目标2将确定人三聚体Fc-epsilon-RI是否在DC上起作用或
巨噬细胞通过IgE介导的摄取途径提呈抗原。这套实验将使用Fcepsilon-
表达RI的小鼠细胞,使我们能够研究受体介导的功能后果
MHC II类和MHC I类途径中T细胞激活的抗原提呈。目标3将
有条件转基因动物体内研究IgE介导的肠道免疫应答
人Fc-epsilon-RIα链在DC上的表达
英文摘要
Abstract
The goal of this research program is to test the hypothesis that dendritic cells (DCs) of the gastro intestinal
tract process lumenal antigens by Fc-epsilon-RI-IgE mediated uptake, thereby affecting the intestinal
inflammatory response and type I hypersensitivity. Fc-epsilon-RI, the high affinity IgE Fc-receptor, is a
multimeric immune recognition receptor that binds IgE through a monovalent epitope in its alpha chain.
Antigen-induced crosslinking of the IgE-Fc-epsilon-RI complex causes cell activation via the signaling subunits
of the receptor (Fc-epsilon-RI-beta and a dimer of the common gamma chain). A unique feature of Fc-epsilon-
RI is its cell type- and species-specific expression pattern. In mice, the receptor is expressed only as a
heterotetramer (alpha, beta, and two gamma chains) on mast cells and basophils. In humans, Fc-epsilon-RI
assembles as a heterotetramer on mast cells and basophils, but additionally also as a heterotrimer lacking the
beta subunit. Uniquely, the human heterotrimeric form of Fc-epsilon-RI is expressed on antigen presenting
cells, including DCs in the intestine. Surface expression of the receptor correlates with allergic diseases, and
controls IgE-mediated cell activation during the allergic response. Unlike other multimeric immune recognition
receptors, surface expression is regulated at the level of co-translational assembly of subunits in the
endoplasmic reticulum; but the mechanism of regulation remains unknown. Aim 1 will elucidate structural
features of individual Fc-epsilon-RI subunits that dictate receptor assembly and thus surface expression of Fcepsilon-
RI complexes. Aim 2 will determine if the human trimeric Fc-epsilon-RI functions on DCs or
macrophages to present antigen via IgE-mediated uptake pathways. This set of experiments will use Fcepsilon-
RI-expressing murine cells that allow us to study functional consequences of receptor-mediated
antigen presentation for T cell activation in the MHC class II and the MHC class I pathways. Aim 3 will
investigate IgE-mediated intestinal immune responses in vivo using a transgenic animal conditionally
expressing the human alpha-chain of Fc-epsilon-RI on DCs.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.imlet.2011.08.004
发表时间:
2011-12-30
期刊:
IMMUNOLOGY LETTERS
影响因子:
4.4
作者:
[Platzer, Barbara, Ruiter, Floortje, van der Mee, John, Fiebiger, Edda]
通讯作者:
Fiebiger, Edda
How to connect an IgE-driven response with CTL activity?
如何将 IgE 驱动的反应与 CTL 活动联系起来?
DOI:
10.1007/s00262-011-1127-y
发表时间:
2012
期刊:
Cancer immunology, immunotherapy : CII
影响因子:
--
作者:
[Platzer,Barbara, Dehlink,Eleonora, Turley,ShannonJ, Fiebiger,Edda]
通讯作者:
Fiebiger,Edda
Studies of Fc-epsilon-RI as an antigen presentation structure at mucosal surfaces
-
批准号:8079461
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2009
-
负责人:Elisabeth Edda Fiebiger
-
依托单位:
Studies of Fc-epsilon-RI as an antigen presentation structure at mucosal surfaces
-
批准号:7867985
-
项目类别:
-
资助金额:$42.49万
-
财政年份:2009
-
负责人:Elisabeth Edda Fiebiger
-
依托单位:
Studies of Fc-epsilon-RI as an antigen presentation structure at mucosal surfaces
-
批准号:8468097
-
项目类别:
-
资助金额:$40.08万
-
财政年份:2009
-
负责人:Elisabeth Edda Fiebiger
-
依托单位:
Studies of Fc-epsilon-RI as an antigen presentation structure at mucosal surfaces
-
批准号:8274711
-
项目类别:
-
资助金额:$42.63万
-
财政年份:2009
-
负责人:Elisabeth Edda Fiebiger
-
依托单位:
Studies of Fc-epsilon-RI as an antigen presentation structure at mucosal surfaces
-
批准号:7725413
-
项目类别:
-
资助金额:$31.94万
-
财政年份:2009
-
负责人:Elisabeth Edda Fiebiger
-
依托单位:
海外基金